Read about Endologix
in the news

Embrace the evidence.

The Latest:

Endologix Announces 36-Month Results of DETOUR2 Study at 2024 VIVA Late-Breaking Clinical Trial Session

See Release

All News

Archives

Endologix Initiates Percutaneous Transmural Arterial Bypass (PTAB)1 Post-Market Study

Endologix Announces that Art Taylor Joins Board of Directors

Endologix Announces that Scott Ward Joins Board of Directors

Endologix announces the U. S. Centers for Medicare & Medicaid Services granted a Transitional Pass-Through (TPT) Payment for the DETOUR™ System

Endologix to Present in Two Upcoming Healthcare Conferences.